Magnetic resonance imaging (MRI) is one of the mainstay imaging modalities for musculoskeletal (MSK) imaging due to its superb inherent soft-tissue contrast,
and the ability to visualise and analyse both normal anatomic structures and pathologic processes.
MSK MRI can be broadly grouped into three categories of disease (1) tumour and tumour-like conditions (2) infection and (3) joint based pathology.
Gadolinium has been considered very safe with serious adverse risks...
Methods and Materials
We wanted to gauge the current practices of British and International MSK Radiologists of the use of gadolinium for MSK extra-spinal imaging.
We anonymously surveyed the members of the British Society of Skeletal Radiologists (BSSR),
European Society of Musculoskeletal Radiology (ESSR) and the Musculoskeletal Society of India (MSS).
We present the results along with discussing the role of contrast enhanced MRI in MSK imaging. Do you use contrast in Musculoskeletal MR Imaging? Yes No Relative...
Results: There were 112 responses from BSSR members and 84 responses from ESSR/MSS. From 112 BSSR survey responses the following question answered breakdown was seen: Q1.
98 answered; 15 skipped Q2.
98 answered; 15 skipped Q3.
99 answered; 14 skipped Q4.
98 answered; 15 skipped Q5.
99 answered; 14 skipped Q6.
97 answered; 16 skipped Q7.
99 answered; 14 skipped Q8.
99 answered; 14 skipped Q9.
112 answered From 84 ESSR/MS survey responses the following question answered breakdown was seen: Q1....
Majority of Radiologists surveyed use gadolinium for extra-axial MSK imaging.
Gadolinium has a role as a problem solver and its use should be restricted to absolutely necessity and where the diagnosis or management is going to change. For example,
gadolinium use for bone tumour imaging has negligible benefit as seen in Figure 11.
patients will have bone scans for skip lesions and the contrast resolution and tissue characterisation of unenhanced MRI can often lead to appropriate...
Bydder GM et al.
Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.
AJR Am J Roentgenol 1984;143(2): 215–24. Lohrke J,
Endrikat J et al.
25 years of contrast-enhanced MRI: Developments,
current challenges and future perspectives.
Adv Ther 2016; 33(1): 1–28. Kanda T,
Matsuda M et al.
Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain...
Dr Amit Shah - Consultant Musculoskeletal Radiologist,
University Hospitals of Leicester,
UK. Dr Rajesh Botchu - Consultant Musculoskeletal Radiologist,
Royal Orthopaedic Hospital,